Private Equity Profile
In the last 3 years, Aisling Capital has acquired 1 company. It has also invested in 13 others.
Aisling Capital’s most common sectors for investment are life science (79%) and medical products (15%). The Firm’s most common investment types include venture (48%) and pipe (27%). In total, Aisling Capital has invested in 14 US states and 3 different countries. Its largest (disclosed) acquisition occurred in 2007 when it acquired Catalent for $3.3B.
In the last 3 years, Aisling Capital has exited 2 companies. The Firm’s most common exit type is trade sale (72%). Aisling Capital’s largest (disclosed) exit occurred in 2017 when it sold ZELTIQ Aesthetics for $2.5B.
Join Mergr to view Aisling Capital’s full profile and discover more large private equity firms just like it.
M&A Total Activity88
- M&A Buy Activity57
- M&A Sell Activity31
- Total Sectors Invested 5
- Total Countries Invested 3
- M&A Buy/Sell Connections 34
- M&A Advisors 3